Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation

Pain

Volumn 138, Issue 2, 2008, Pages 423-439

  Schepers, R J ^a,b   Mahoney, Janet Lynn ^b   Gehrke, Brenda Jean ^b   Shippenberg, Toni Shaun ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

CFA; Gene deletion; Inflammation; Kappa opioid receptor; Knockout; Mouse; Norbinaltorphimine; Rat; Rostral ventromedial medulla; Spinal cord

Indexed keywords

FREUND ADJUVANT; KAPPA OPIATE RECEPTOR; NORBINALTORPHIMINE; OPIATE RECEPTOR;

ADAPTATION; ANIMAL EXPERIMENT; ARTICLE; CONTROL SYSTEM; CONTROLLED STUDY; GENE DELETION; HYPERALGESIA; HYPERSENSITIVITY; INFLAMMATION; MECHANICAL STIMULATION; MEDULLA OBLONGATA; MOUSE; NOCICEPTION; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; RECEPTOR GENE; RECEPTOR SENSITIVITY; SENSITIZATION; SPINAL CORD; THERMAL STIMULATION;

ANALGESICS, OPIOID; ANIMALS; HYPERALGESIA; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA;

EID: 49049111799     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2008.01.023     Document Type: Article

References (87)

1. Antic J., Vasiljevic T., Stanojevic S., Vujic V., Kovacevic-Jovanovic V., Djergovic D., et al. Suppression of adjuvant arthritis by kappa-opioid receptor agonist: effect of route of administration and strain differences. Immunopharmacology 34 (1996) 105-112
2. Bennett A.D., Everhart A.W., and Hulsebosch C.E. Intrathecal administration of an NMDA or a non-NMDA receptor antagonist reduces mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury. Brain Res 859 (2000) 72-82
3. Bilsky E.J., Wang T., Lai J., and Porreca F. Selective blockade of peripheral delta opioid agonist induced antinociception by intrathecal administration of delta receptor antisense oligodeoxynucleotide. Neurosci Lett 220 (1996) 155-158
4. Broadbear J.H., Negus S.S., Butelman E.R., de Costa B.R., and Woods J.H. Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay. Psychopharmacology (Berl) 115 (1994) 311-319
5. Butelman E.R., Negus S.S., Ai Y., de Costa B.R., and Woods J.H. Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys. J Pharmacol Exp Ther 267 (1993) 1269-1276
6. Calderon S.N., Rothman R.B., Porreca F., Flippen-Anderson J.L., McNutt R.W., Xu H., et al. Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist. J Med Chem 37 (1994) 2125-2128
7. Campbell J.N., Raja S.N., Meyer R.A., and Mackinnon S.E. Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain 32 (1988) 89-94
8. Caudle R.M., and Mannes A.J. Dynorphin: friend or foe?. Pain 87 (2000) 235-239
9. Chang A.C., Cowan A., Takemori A.E., and Portoghese P.S. Aspartic acid conjugates of 2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1(3-aminophenyl)-2-(1-pyrrolidinyl)ethyl]acetamide: kappa opioid receptor agonists with limited access to the central nervous system. J Med Chem 39 (1996) 4478-4482
10. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53 (1994) 55-63
11. Chavkin C., James I.F., and Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215 (1982) 413-415
12. Chefer V.I., Czyzyk T., Bolan E.A., Moron J., Pintar J.E., and Shippenberg T.S. Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. J Neurosci 25 (2005) 5029-5037
13. Choi S.S., Han K.J., Lee H.K., Han E.J., and Suh H.W. Possible antinociceptive mechanisms of opioid receptor antagonists in the mouse formalin test. Pharmacol Biochem Behav 75 (2003) 447-457
14. DeLean A., Munson P.J., and Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235 (1978) E97-E102
15. Endoh T., Matsuura H., Tanaka C., and Nagase H. Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther 316 (1992) 30-42
16. Endoh T., Tajima A., Suzuki T., Kamei J., Narita M., Tseng L., et al. Characterization of the antinociceptive effects of TRK-820 in the rat. Eur J Pharmacol 387 (2000) 133-140
17. Gardell L.R., Ossipov M.H., Vanderah T.W., Lai J., and Porreca F. Dynorphin-independent spinal cannabinoid antinociception. Pain 100 (2002) 243-248
18. Gogas K.R., Levine J.D., and Basbaum A.I. Differential contribution of descending controls to the antinociceptive actions of kappa and mu opioids: an analysis of formalin-evoked C-fos expression. J Pharmacol Exp Ther 276 (1996) 801-809
19. Greenspan J.D., and McGillis S.L. Stimulus features relevant to the perception of sharpness and mechanically evoked cutaneous pain. Somatosens Mot Res 8 (1991) 137-147
20. Grossman A., and Clement-Jones V. Opiate receptors: enkephalins and endorphins. Clin Endocrinol Metab 12 (1983) 31-56
21. Guirimand F., Strimbu-Gozariu M., Willer J.C., and Le Bars D. Effects of mu, delta and kappa opioid antagonists on the depression of a C-fiber reflex by intrathecal morphine and DAGO in the rat. J Pharmacol Exp Ther 269 (1994) 1007-1020
22. Herdegen T., Leah J.D., Manisali A., Bravo R., and Zimmermann M. c-JUN-like immunoreactivity in the CNS of the adult rat: basal and transynaptically induced expression of an immediate-early gene. Neuroscience 41 (1991) 643-654
23. Herdegen T., Tolle T.R., Bravo R., Zieglgansberger W., and Zimmermann M. Sequential expression of JUN B, JUN D and FOS B proteins in rat spinal neurons: cascade of transcriptional operations during nociception. Neurosci Lett 129 (1991) 221-224
24. Hirata H., Pataky A., Kajander K., LaMotte R.H., and Collins J.G. A model of peripheral mononeuropathy in the rat. Pain 42 (1990) 253-255
25. Ho J., Mannes A.J., Dubner R., and Caudle R.M. Putative kappa-2 opioid agonists are antihyperalgesic in a rat model of inflammation. J Pharmacol Exp Ther 281 (1997) 136-141
26. Horan P., Taylor J., Yamamura H.I., and Porreca F. Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther 260 (1992) 1237-1243
27. Hough L.B., Nalwalk J.W., Chen Y., Schuller A., Zhu Y., Zhang J., et al. Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice. Brain Res 880 (2000) 102-108
28. Iadarola M.J., Brady L.S., Draisci G., and Dubner R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain 35 (1988) 313-326
29. Janson W., and Stein C. Peripheral opioid analgesia. Curr Pharm Biotechnol 4 (2003) 270-274
30. Janssen P.A., Niemegeers C.J., and Dony J.G. The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats. Arzneimittelforschung 13 (1963) 502-507
31. Joris J.L., Dubner R., and Hargreaves K.M. Opioid analgesia at peripheral sites: a target for opioids released during stress and inflammation?. Anesth Analg 66 (1987) 1277-1281
32. Kolhekar R., Meller S.T., and Gebhart G.F. N-methyl-d-aspartate receptor-mediated changes in thermal nociception: allosteric modulation at glycine and polyamine recognition sites. Neuroscience 63 (1994) 925-936
33. Koltzenburg M., Lundberg L.E., and Torebjork H.E. Dynamic and static components of mechanical hyperalgesia in human hairy skin. Pain 51 (1992) 207-219
34. Koltzenburg M., Torebjork H.E., and Wahren L.K. Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain. Brain 117 (1994) 579-591
35. Kong L.L., and Yu L.C. Involvement of mu- and delta-opioid receptors in the antinociceptive effects induced by AMPA receptor antagonist in the spinal cord of rats. Neurosci Lett 402 (2006) 180-183
36. Lahti R.A., Mickelson M.M., McCall J.M., and Von Voigtlander P.F. [3H]U-69593 a highly selective ligand for the opioid kappa receptor. Eur J Pharmacol 109 (1985) 281-284
37. Lai J., Luo M.C., Chen Q., Ma S., Gardell L.R., Ossipov M.H., et al. Dynorphin A activates bradykinin receptors to maintain neuropathic pain. Nat Neurosci 9 (2006) 1534-1540
38. Levin S., Pearsall G., and Ruderman R.J. Von Frey's method of measuring pressure sensibility in the hand: an engineering analysis of the Weinstein-Semmes pressure aesthesiometer. J Hand Surg [Am] 3 (1978) 211-216
39. MacArthur L., Ren K., Pfaffenroth E., Franklin E., and Ruda M.A. Descending modulation of opioid-containing nociceptive neurons in rats with peripheral inflammation and hyperalgesia. Neuroscience 88 (1999) 499-506
40. Maekawa K., Minami M., Masuda T., and Satoh M. Expression of mu- and kappa-, but not delta-, opioid receptor mRNAs is enhanced in the spinal dorsal horn of the arthritic rats. Pain 64 (1996) 365-371
41. Mansikka H., Sheth R.N., DeVries C., Lee H., Winchurch R., and Raja S.N. Nerve injury-induced mechanical but not thermal hyperalgesia is attenuated in neurokinin-1 receptor knockout mice. Exp Neurol 162 (2000) 343-349
42. Mansikka H., Zhao C., Sheth R.N., Sora I., Uhl G., and Raja S.N. Nerve injury induces a tonic bilateral mu-opioid receptor-mediated inhibitory effect on mechanical allodynia in mice. Anesthesiology 100 (2004) 912-921
43. Mapp P.I., Terenghi G., Walsh D.A., Chen S.T., Cruwys S.C., Garrett N., et al. Monoarthritis in the rat knee induces bilateral and time-dependent changes in substance P and calcitonin gene-related peptide immunoreactivity in the spinal cord. Neuroscience 57 (1993) 1091-1096
44. Martin M., Matifas A., Maldonado R., and Kieffer B.L. Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones. Eur J Neurosci 17 (2003) 701-708
45. McCurdy C.R., Sufka K.J., Smith G.H., Warnick J.E., and Nieto M.J. Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist. Pharmacol Biochem Behav 83 (2006) 109-113
46. Meert T.F., and Vermeirsch H.A. A preclinical comparison between different opioids: antinociceptive versus adverse effects. Pharmacol Biochem Behav 80 (2005) 309-326
47. Millan M.J., and Colpaert F.C. 5-Hydroxytryptamine (HT)1A receptors and the tail-flick response. III. Structurally diverse 5-HT1A partial agonists attenuate mu- but not kappa-opioid antinociception in mice and rats. J Pharmacol Exp Ther 256 (1991) 993-1001
48. Millan M.J., Czlonkowski A., Morris B., Stein C., Arendt R., Huber A., et al. Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat. Pain 35 (1988) 299-312
49. Millan M.J., Czlonkowski A., Pilcher C.W., Almeida O.F., Millan M.H., Colpaert F.C., et al. A model of chronic pain in the rat: functional correlates of alterations in the activity of opioid systems. J Neurosci 7 (1987) 77-87
50. Millan M.J., Morris B.J., Colpaert F.C., and Herz A. A model of chronic pain in the rat: high-resolution neuroanatomical approach identifies alterations in multiple opioid systems in the periaqueductal grey. Brain Res 416 (1987) 349-353
51. Mundey M.K., Ali A., Mason R., and Wilson V.G. Pharmacological examination of contractile responses of the guinea-pig isolated ileum produced by mu-opioid receptor antagonists in the presence of, and following exposure to, morphine. Br J Pharmacol 131 (2000) 893-902
52. *)-4a-(3-hydroxyphenyl)-2-methyl-1,2,3,4,4a,5,12,12a-octahydropyrido[3,4-b]acridine (TAN-67). Chem Pharm Bull (Tokyo) 46 (1998) 1695-1702
53. Nahin R.L., Hylden J.L., and Humphrey E. Demonstration of dynorphin A 1-8 immunoreactive axons contacting spinal cord projection neurons in a rat model of peripheral inflammation and hyperalgesia. Pain 51 (1992) 135-143
54. Neil A., Kayser V., Gacel G., Besson J.M., and Guilbaud G. Opioid receptor types and antinociceptive activity in chronic inflammation: both kappa- and mu-opiate agonistic effects are enhanced in arthritic rats. Eur J Pharmacol 130 (1986) 203-208
55. Nicholson J.R., Paterson S.J., Menzies J.R., Corbett A.D., and McKnight A.T. Pharmacological studies on the "orphan" opioid receptor in central and peripheral sites. Can J Physiol Pharmacol 76 (1998) 304-313
56. Obara I., Mika J., Schafer M.K., and Przewlocka B. Antagonists of the kappa-opioid receptor enhance allodynia in rats and mice after sciatic nerve ligation. Br J Pharmacol 140 (2003) 538-546
57. Ossipov M.H., Kovelowski C.J., Wheeler-Aceto H., Cowan A., Hunter J.C., Lai J., et al. Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid kappa and delta inhibitory tone. J Pharmacol Exp Ther 277 (1996) 784-788
58. Parra M.C., Nguyen T.N., Hurley R.W., and Hammond D.L. Persistent inflammatory nociception increases levels of dynorphin 1-17 in the spinal cord, but not in supraspinal nuclei involved in pain modulation. J Pain 3 (2002) 330-336
59. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1998), Academic Press, San Diego
60. Petko M., and Antal M. Propriospinal afferent and efferent connections of the lateral and medial areas of the dorsal horn (laminae I-IV) in the rat lumbar spinal cord. J Comp Neurol 422 (2000) 312-325
61. Przewlocki R., Stala L., Greczek M., Shearman G.T., Przewlocka B., and Herz A. Analgesic effects of mu-, delta- and kappa-opiate agonists and, in particular, dynorphin at the spinal level. Life Sci 33 (1983) 649-652
62. Randich A., Meller S.T., and Gebhart G.F. Responses of primary afferents and spinal dorsal horn neurons to thermal and mechanical stimuli before and during zymosan-induced inflammation of the rat hindpaw. Brain Res 772 (1997) 135-148
63. Ren K., and Ruda M.A. Descending modulation of Fos expression after persistent peripheral inflammation. Neuroreport 7 (1996) 2186-2190
64. Schepers R.J., Mahoney J.L., and Shippenberg T.S. Inflammation-induced changes in rostral ventromedial medulla mu and kappa opioid receptor mediated antinociception. Pain (2007)
65. Sharifi N., Diehl N., Yaswen L., Brennan M.B., and Hochgeschwender U. Generation of dynorphin knockout mice. Brain Res Mol Brain Res 86 (2001) 70-75
66. Sofuoglu M., Portoghese P.S., and Takemori A.E. Maintenance of acute morphine tolerance in mice by selective blockage of kappa opioid receptors with norbinaltorphimine. Eur J Pharmacol 210 (1992) 159-162
67. Sotgiu M.L., Brambilla M., Valente M., and Biella G.E. Contralateral input modulates the excitability of dorsal horn neurons involved in noxious signal processes. Potential role in neuronal sensitization. Somatosens Mot Res 21 (2004) 211-215
68. Sotgiu M.L., Valente M., Caramenti G.C., and Biella G.E. Heterotopic inputs facilitate poststimulus after discharges of spinal WDR neurons in rats with chronic nerve constriction. Brain Res 1099 (2006) 97-100
69. Spanagel R., Almeida O.F., and Shippenberg T.S. Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes. Eur J Pharmacol 264 (1994) 157-162
70. Stanfa L., and Dickenson A. Spinal opioid systems in inflammation. Inflamm Res 44 (1995) 231-241
71. Stanfa L.C., Sullivan A.F., and Dickenson A.H. Alterations in neuronal excitability and the potency of spinal mu, delta and kappa opioids after carrageenan-induced inflammation. Pain 50 (1992) 345-354
72. Stein C., Millan M.J., and Herz A. Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds. Pharmacol Biochem Behav 31 (1988) 451-455
73. Stiller R.U., Grubb B.D., and Schaible H.G. Neurophysiological evidence for increased kappa opioidergic control of spinal cord neurons in rats with unilateral inflammation at the ankle. Eur J Neurosci 5 (1993) 1520-1527
74. Storkson R.V., Kjorsvik A., Tjolsen A., and Hole K. Lumbar catheterization of the spinal subarachnoid space in the rat. J Neurosci Methods 65 (1996) 167-172
75. Tokuyama S., Nagae R., Mashida E., and Hamabe W. Involvement of kappa opioid receptors in formalin-induced inhibition of analgesic tolerance to morphine in mice. J Pharm Pharmacol 59 (2007) 1109-1115
76. Torebjork H.E., Lundberg L.E., and LaMotte R.H. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol 448 (1992) 765-780
77. Vanegas H., and Schaible H.G. Descending control of persistent pain: inhibitory or facilitatory?. Brain Res Brain Res Rev 46 (2004) 295-309
78. Wagner R., DeLeo J.A., Coombs D.W., Willenbring S., and Fromm C. Spinal dynorphin immunoreactivity increases bilaterally in a neuropathic pain model. Brain Res 629 (1993) 323-326
79. Wang Z., Gardell L.R., Ossipov M.H., Vanderah T.W., Brennan M.B., Hochgeschwender U., et al. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci 21 (2001) 1779-1786
80. Wei F., Ren K., and Dubner R. Inflammation-induced Fos protein expression in the rat spinal cord is enhanced following dorsolateral or ventrolateral funiculus lesions. Brain Res 782 (1998) 136-141
81. Wells J.L., Bartlett J.L., Ananthan S., and Bilsky E.J. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence. J Pharmacol Exp Ther 297 (2001) 597-605
82. Wu H.E., Hung K.C., Mizoguchi H., Nagase H., and Tseng L.F. Roles of endogenous opioid peptides in modulation of nocifensive response to formalin. J Pharmacol Exp Ther 300 (2002) 647-654
83. Xu M., Petraschka M., McLaughlin J.P., Westenbroek R.E., Caron M.G., Lefkowitz R.J., et al. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. J Neurosci 24 (2004) 4576-4584
84. Yeomans D.C., Pirec V., and Proudfit H.K. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: behavioral evidence. Pain 68 (1996) 133-140
85. Yeomans D.C., and Proudfit H.K. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: electrophysiological evidence. Pain 68 (1996) 141-150
86. Yu L.C., Lu J.T., Huang Y.H., Meuser T., Pietruck C., Gabriel A., et al. Involvement of endogenous opioid systems in nociceptin-induced spinal antinociception in rats. Brain Res 945 (2002) 88-96
87. Zimmerman M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110